Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-12-15
pubmed:abstractText
Six novel ibuprofen derivatives and related structures, incorporating a proline moiety and designed for neurodegenerative disorders, are studied. They possess anti-inflammatory properties and three of them inhibited lipoxygenase. One compound was found to inhibit cyclooxygenase (COX)-2 production in spleenocytes from arthritic rats. The HS-containing compounds are potent antioxidants and one of them protected against glutathione loss after cerebral ischemia/reperfusion. They demonstrated lipid-lowering ability and seem to acquire low gastrointestinal toxicity. Acetylcholinesterase inhibitory activity, found in two of these compounds, may be an asset to their actions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2,2-diphenyl-1-picrylhydrazyl, http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants, http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Freund's Adjuvant, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione, http://linkedlifedata.com/resource/pubmed/chemical/Ibuprofen, http://linkedlifedata.com/resource/pubmed/chemical/Lipoxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Nootropic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Picrates, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0968-0896
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
951-61
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17126019-Animals, pubmed-meshheading:17126019-Antioxidants, pubmed-meshheading:17126019-Arthritis, Experimental, pubmed-meshheading:17126019-Biphenyl Compounds, pubmed-meshheading:17126019-Blood-Brain Barrier, pubmed-meshheading:17126019-Cholesterol, pubmed-meshheading:17126019-Cholinesterase Inhibitors, pubmed-meshheading:17126019-Cyclooxygenase 2 Inhibitors, pubmed-meshheading:17126019-Freund's Adjuvant, pubmed-meshheading:17126019-Gastrointestinal Diseases, pubmed-meshheading:17126019-Glutathione, pubmed-meshheading:17126019-Hyperlipidemias, pubmed-meshheading:17126019-Hypoxia-Ischemia, Brain, pubmed-meshheading:17126019-Ibuprofen, pubmed-meshheading:17126019-Lipid Peroxidation, pubmed-meshheading:17126019-Lipoxygenase Inhibitors, pubmed-meshheading:17126019-Mice, pubmed-meshheading:17126019-Microsomes, Liver, pubmed-meshheading:17126019-Neuroprotective Agents, pubmed-meshheading:17126019-Nootropic Agents, pubmed-meshheading:17126019-Oxidative Stress, pubmed-meshheading:17126019-Picrates, pubmed-meshheading:17126019-Rats, pubmed-meshheading:17126019-Spleen, pubmed-meshheading:17126019-Triglycerides
pubmed:year
2007
pubmed:articleTitle
Design and study of some novel ibuprofen derivatives with potential nootropic and neuroprotective properties.
pubmed:affiliation
Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotelian University of Thessaloniki, Thessaloniki 54124, Greece.
pubmed:publicationType
Journal Article